Document is current
Any future updates will be listed below
-
Authors
Pan, Zixuan
Marra, Alberto M.
Benjamin, Nicola
Eichstaedt, Christina A.
Blank, Norbert
Bossone, Eduardo
Cittadini, Antonio
Coghlan, Gerry
Denton, Christopher P.
Distler, Oliver
Egenlauf, Benjamin
Fischer, Christine
Harutyunova, Satenik
Xanthouli, Panagiota
Lorenz, Hanns-Martin
Grünig, Ekkehard
-
Funding
Funding for this research was provided by:
GlaxoSmithKline
- License Information
-
More Information
Article History
Received: 12 June 2019
Accepted: 16 August 2019
First Online: 26 October 2019
Ethics approval and consent to participate
: A written informed consent was obtained from all patients in accordance with the Declaration of Helsinki. The approval of the ethics committee of the Medical Faculty Heidelberg was obtained (AFmo-407/2014).
: Not applicable.
: ZP, AMM, CAE, EB, AC, CF, and PX declare that they have no competing interests. NBe has received speaker honoraria from Actelion pharmaceuticals, not related to this study. NoB has received speaker honoraria from Actelion pharmaceuticals, not related to this study. GC reports research support, consultancy fees, and speaker honoraria from Actelion pharmaceuticals. CPD reports speaker honoraria from Actelion pharmaceuticals. OD reports research support and consultancy fees from Actelion pharmaceuticals. BE reports speaker honoraria from Actelion pharmaceuticals. SH reports speaker honoraria from Actelion pharmaceuticals. HML reports speaker and consultancy fees from Actelion pharmaceuticals. EG has received speaker honoraria and advisory board fees from Actelion pharmaceuticals.
